6 pending office actions • 5 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready
Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (17%) |
| §103 only | 3 (50%) |
| §102 only | 2 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| VAN BUREN, LAUREN K | 1 | 38.9% | +57.3% |
| TAKENAKA, RISA | 1 | 15.4% | +100.0% |
| TRAN, KHOA NHAT | 1 | 35.4% | +66.3% |
| BARRON, SEAN C | 1 | 53.5% | +30.9% |
| TIWARI, VYOMA SHUBHAM | 1 | 30.2% | +46.7% |
| KRCHA, MATTHEW D | 1 | 65.9% | +35.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18048291 | ENHANCED PLACENTAL STEM CELLS AND USES THEREOF | TAKENAKA, RISA | 60d overdue |
| 17309451 | PLACENTA-DERIVED ALLOGENEIC CAR-T CELLS AND USES THEREOF | TIWARI, VYOMA SHUBHAM | 20d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17998199 | PLACENTA-DERIVED ADHERENT (PDA) STEM CELL FOR THE TREATMENT OF ADULTS WITH SARS-COV-2 RELATED ACUTE RESPIRATORY FAILURE AND ARDS (COVID-19) | VAN BUREN, LAUREN K | 210d overdue |
| 17630079 | POPULATIONS OF NATURAL KILLER CELLS COMPRISING A CD38 CHIMERIC ANTIGEN RECEPTOR | TRAN, KHOA NHAT | 155d overdue |
| 17302353 | DEVICES AND METHODS FOR THAWING BIOLOGICAL MATERIAL | KRCHA, MATTHEW D | 124d overdue |
| 18048291 | ENHANCED PLACENTAL STEM CELLS AND USES THEREOF | TAKENAKA, RISA | 60d overdue |
| 17619242 | POPULATIONS OF NATURAL KILLER CELLS FOR TREATING CANCERS | BARRON, SEAN C | 5d |
| 17309451 | PLACENTA-DERIVED ALLOGENEIC CAR-T CELLS AND USES THEREOF | TIWARI, VYOMA SHUBHAM | 20d |
| Art Unit | Apps |
|---|---|
| 1632 | 2 |
| 1638 | 1 |
| 1653 | 1 |
| 1634 | 1 |
| 1796 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17998199 | PLACENTA-DERIVED ADHERENT (PDA) STEM CELL FOR THE TREATMENT OF ADULTS WITH SARS-COV-2 RELATED ACUTE RESPIRATORY FAILURE AND ARDS (COVID-19) | VAN BUREN, LAUREN K | 1638 | §102 | Non-Final OA | 210d overdue | Pending | Nov 08, 2022 |
| 18048291 | ENHANCED PLACENTAL STEM CELLS AND USES THEREOF | TAKENAKA, RISA | 1632 | §103 | Final Rejection | 60d overdue | Pending | Oct 20, 2022 |
| 17630079 | POPULATIONS OF NATURAL KILLER CELLS COMPRISING A CD38 CHIMERIC ANTIGEN RECEPTOR | TRAN, KHOA NHAT | 1632 | §103 | Non-Final OA | 155d overdue | Pending | Jan 25, 2022 |
| 17619242 | POPULATIONS OF NATURAL KILLER CELLS FOR TREATING CANCERS | BARRON, SEAN C | 1653 | §103 | Non-Final OA | 5d | Pending | Dec 14, 2021 |
| 17309451 | PLACENTA-DERIVED ALLOGENEIC CAR-T CELLS AND USES THEREOF | TIWARI, VYOMA SHUBHAM | 1634 | §101 | Non-Final OA | 20d | Pending | May 27, 2021 |
| 17302353 | DEVICES AND METHODS FOR THAWING BIOLOGICAL MATERIAL | KRCHA, MATTHEW D | 1796 | §102 | Final Rejection | 124d overdue | Pending | Apr 30, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial